Innovent Biologics, Inc. (1801.HK)

HKD 36.2

(-0.82%)

Inventory Summary of Innovent Biologics, Inc.

Innovent Biologics, Inc.'s latest annual inventory in 2023 was 968.08 Million CNY , down -32.25% from previous year.
Innovent Biologics, Inc.'s latest quarterly inventory in 2023 FY was 968.08 Million CNY , down -32.25% from previous quarter.
Innovent Biologics, Inc. reported annual inventory of 1.42 Billion CNY in 2022, up 6.06% from previous year.
Innovent Biologics, Inc. reported annual inventory of 1.34 Billion CNY in 2021, up 90.92% from previous year.
Innovent Biologics, Inc. reported quarterly inventory of 968.08 Million CNY for 2023 Q4, down 0.0% from previous quarter.
Innovent Biologics, Inc. reported quarterly inventory of 968.08 Million CNY for 2023 FY, down -32.25% from previous quarter.

Annual Inventory Chart of Innovent Biologics, Inc. (2023 - 2016)

Historical Annual Inventory of Innovent Biologics, Inc. (2023 - 2016)

Year	Inventory	Inventory Growth
2023	968.08 Million CNY	-32.25%
2022	1.42 Billion CNY	6.06%
2021	1.34 Billion CNY	90.92%
2020	705.65 Million CNY	96.78%
2019	358.59 Million CNY	442.33%
2018	66.12 Million CNY	14.55%
2017	57.72 Million CNY	57.58%
2016	36.63 Million CNY	0.0%

Year	Inventory	Inventory Growth
2023 Q2	1.3 Billion CNY	0.0%
2023 Q4	968.08 Million CNY	0.0%
2023 FY	968.08 Million CNY	-32.25%
2023 Q3	968.08 Million CNY	-25.53%
2023 Q1	1.3 Billion CNY	-9.02%
2022 Q1	1.47 Billion CNY	9.63%
2022 FY	1.42 Billion CNY	6.06%
2022 Q3	1.42 Billion CNY	-3.25%
2022 Q2	1.47 Billion CNY	0.0%
2022 Q4	1.42 Billion CNY	0.0%
2021 Q3	1.34 Billion CNY	22.29%
2021 FY	1.34 Billion CNY	90.92%
2021 Q1	1.1 Billion CNY	56.11%
2021 Q2	1.1 Billion CNY	0.0%
2021 Q4	1.34 Billion CNY	0.0%
2020 Q1	467.13 Million CNY	30.27%
2020 Q3	705.65 Million CNY	51.06%
2020 Q2	467.13 Million CNY	0.0%
2020 Q4	705.65 Million CNY	0.0%
2020 FY	705.65 Million CNY	96.78%
2019 FY	358.59 Million CNY	442.33%
2019 Q4	358.59 Million CNY	0.0%
2019 Q3	358.59 Million CNY	54.85%
2019 Q2	231.58 Million CNY	0.0%
2019 Q1	231.58 Million CNY	250.24%
2018 Q1	48.98 Million CNY	-15.15%
2018 Q3	66.12 Million CNY	35.0%
2018 FY	66.12 Million CNY	14.55%
2018 Q4	66.12 Million CNY	0.0%
2018 Q2	48.98 Million CNY	0.0%
2017 Q3	57.72 Million CNY	0.0%
2017 Q1	- CNY	0.0%
2017 Q4	57.72 Million CNY	0.0%
2017 FY	57.72 Million CNY	57.58%
2016 FY	36.63 Million CNY	0.0%

Peer Inventory Comparison of Innovent Biologics, Inc.

Name	Inventory	Inventory Difference
Uni-Bio Science Group Limited	36.39 Million HKD	-2560.167%
CK Life Sciences Int'l., (Holdings) Inc.	1.2 Billion HKD	19.63%